CLL: Treatment and Management Strategies for Best Outcomes - Episode 8
Focusing on acalabrutinib-based treatment, Yuliya Linhares, MD, discusses results from the ELEVATE TN clinical trial.
Related Content:
Early Detection and Misconceptions in Lung Cancer
FDA Grants Breakthrough Therapy Designation to Ficerafusp Alfa in Head and Neck Cancer
What the FDA Approval of Inluriyo Means for Patients With Breast Cancer
Pelvic Health Therapy Helps Women Reclaim Comfort After Cancer